Karl-Patrik Kresoja
Overview
Explore the profile of Karl-Patrik Kresoja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pagnesi M, Adamo M, Stolz L, Pancaldi E, Kresoja K, von Stein J, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39980251
Aims: The impact of malnutrition in patients with tricuspid regurgitation (TR) undergoing tricuspid transcatheter edge-to-edge repair (T-TEER) is not well established. We evaluated the impact of malnutrition among patients with...
2.
Schlotter F, Stolz L, Kresoja K, von Stein J, Fortmeier V, Koell B, et al.
JACC Cardiovasc Interv
. 2025 Feb;
18(3):339-348.
PMID: 39939038
Background: Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as a treatment option for patients with severe tricuspid regurgitation (TR). However, randomized trials have not shown a survival benefit, possibly because...
3.
Stolz L, Kalbacher D, Koell B, Karam N, Puscas T, Metra M, et al.
Clin Res Cardiol
. 2025 Feb;
PMID: 39909890
No abstract available.
4.
Koppe-Schmeisser F, Fengler K, Kresoja K, Lurz P, Rommel K
Heart Fail Rev
. 2025 Jan;
PMID: 39875629
Renal Denervation (RDN) has emerged over the last decade as a third pillar in the treatment of arterial hypertension, alongside pharmacotherapy and lifestyle modifications. Mechanistically, it reduces central sympathetic overactivation,...
5.
Velollari O, Rommel K, Kresoja K, Lurz P, Gori T
Heart Fail Rev
. 2025 Jan;
PMID: 39804445
Heart failure is a prevalent global health issue. Heart failure with preserved ejection fraction (HFpEF), which already represents half of all heart cases worldwide, is projected to further increase, driven...
6.
Lurz P, Zancanaro E, Kresoja K
Eur Heart J
. 2025 Jan;
46(10):882-884.
PMID: 39797420
No abstract available.
7.
Kresoja K, Zeymer U, Thevathasan T, Rassaf T, Jung C, Poss J, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(2):273-275.
PMID: 39708014
No abstract available.
8.
Stolz L, Kresoja K, von Stein J, Fortmeier V, Koell B, Rottbauer W, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(23):2781-2791.
PMID: 39663058
Background: Atrial secondary tricuspid regurgitation (A-STR) has been proposed as an important etiologic subentity of secondary tricuspid regurgitation (STR). Patients with A-STR are frequently treated using transcatheter tricuspid valve edge-to-edge...
9.
Kassar M, Brugger N, Stolz L, Gercek M, Fortmeier V, Kresoja K, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39620495
Aims: Conventional parameters of right ventricular (RV) function are load-dependent and therefore do not accurately reflect contractility in patients with relevant tricuspid regurgitation (TR). RV adaptability to load has been...
10.
Weckbach L, Stolz L, Doldi P, Glaser H, Ennin C, Kothieringer M, et al.
Eur J Heart Fail
. 2024 Nov;
PMID: 39592914
Aims: Right ventricular reverse remodelling (RVRR) is linked to improved survival in patients with severe tricuspid regurgitation (TR) and right-sided heart failure who underwent interventional treatment. However, the role of...